Literature DB >> 20101780

Application of contrast-enhanced intraoperative ultrasonography in the decision-making about hepatocellular carcinoma operation.

Hong Wu1, Qiang Lu, Yan Luo, Xian-Lu He, Yong Zeng.   

Abstract

AIM: To evaluate the detection and differentiation ability of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in hepatocellular carcinoma (HCC) operations.
METHODS: Clinical data of 50 HCC patients were retrospective analyzed. The sensitivity, specificity, false negative and false positive rates of contrast enhanced magnetic resonance imaging (CE-MRI), IOUS and CE-IOUS were calculated and compared. Surgical strategy changes due to CE-IOUS were analyzed.
RESULTS: Lesions detected by CE-MRI, IOUS and CE-IOUS were 60, 97 and 85 respectively. The sensitivity, specificity, false negative rate, false positive rate of CE-MRI were 98.2%, 98.6%, 98.6%, 60.0%, respectively; for IOUS were 50.0%, 90.9%, 1.8%, 1.4%, respectively; and for CE-IOUS were 1.4%, 40.0%, 50.0%, 9.1%, respectively. The operation strategy of 9 (9/50, 18.0%) cases was changed according to the results of CE-IOUS.
CONCLUSION: Compared with CE-MRI, CE-IOUS performs better in detection and differentiation of small metastasis and regenerative nodules. It plays an important role in the decision-making of HCC operation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101780      PMCID: PMC2811807          DOI: 10.3748/wjg.v16.i4.508

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  New lesions detected by intraoperative ultrasound during liver resection for hepatocellular carcinoma.

Authors:  Y Takigawa; Y Sugawara; J Yamamoto; K Shimada; S Yamasaki; T Kosuge; M Makuuchi
Journal:  Ultrasound Med Biol       Date:  2001-02       Impact factor: 2.998

2.  Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.

Authors:  Glenn A Krinsky; Vivian S Lee; Neil D Theise; Jeffrey C Weinreb; Glyn R Morgan; Thomas Diflo; Devon John; Lewis W Teperman; A S Goldenberg
Journal:  Liver Transpl       Date:  2002-12       Impact factor: 5.799

3.  Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver.

Authors:  Alexandra von Herbay; Christoph Vogt; Dieter Häussinger
Journal:  AJR Am J Roentgenol       Date:  2002-11       Impact factor: 3.959

4.  Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions.

Authors:  A Cervone; A Sardi; G L Conaway
Journal:  Am Surg       Date:  2000-07       Impact factor: 0.688

5.  The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging.

Authors:  Rosie Conlon; Michael Jacobs; Dowmitra Dasgupta; J Peter A Lodge
Journal:  Eur J Ultrasound       Date:  2003-02

6.  Results of treatment of primary liver cancer at Kaunas University of Medicine Hospital.

Authors:  Mindaugas Jievaltas; Laura Stoskuviene; Vitalija Petrenkiene; Giedrius Barauskas; Juozas Pundzius
Journal:  Medicina (Kaunas)       Date:  2004       Impact factor: 2.430

7.  Current value of intraoperative sonography during surgery for hepatic neoplasms.

Authors:  Johannes Zacherl; Christian Scheuba; Martin Imhof; Maximilian Zacherl; Friedrich Längle; Peter Pokieser; Fritz Wrba; Etienne Wenzl; Ferdinand Mühlbacher; Raimund Jakesz; Rudolf Steininger
Journal:  World J Surg       Date:  2002-02-14       Impact factor: 3.352

8.  Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes.

Authors:  Lorenzo Capussotti; Andrea Muratore; Paolo Massucco; Alessandro Ferrero; Roberto Polastri; Hedayat Bouzari
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

9.  Value of contrast-enhanced intraoperative ultrasound for cirrhotic patients with hepatocellular carcinoma: a report of 20 cases.

Authors:  Qiang Lu; Yan Luo; Chao-Xin Yuan; Yong Zeng; Hong Wu; Zheng Lei; Yao Zhong; Yu-Ting Fan; Hong-Hao Wang; Yang Luo
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

10.  Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography.

Authors:  Martin Krix; Fabian Kiessling; Marco Essig; Felix Herth; Andreas Karcher; Martin Le-Huu; Hans-Ulrich Kauczor; Stefan Delorme
Journal:  Invest Radiol       Date:  2004-04       Impact factor: 6.016

View more
  5 in total

1.  Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors.

Authors:  M Del Prete; A Di Sarno; R Modica; F Lassandro; A Giorgio; A Bianco; M Muto; M Gasperi; F Del Prete; A Colao; V Montesarchio; A Faggiano
Journal:  J Endocrinol Invest       Date:  2017-06-30       Impact factor: 4.256

2.  Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.

Authors:  Xiao-Yun Zhang; Yan Luo; Tian-Fu Wen; Li Jiang; Chuan Li; Xiao-Fei Zhong; Jing-Yi Zhang; Wen-Wu Ling; Lu-Nan Yan; Yong Zeng; Hong Wu
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 3.  Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.

Authors:  Tianfu Wen; Chen Jin; Antonio Facciorusso; Matteo Donadon; Ho-Seong Han; Yilei Mao; Chaoliu Dai; Shuqun Cheng; Bixiang Zhang; Baogang Peng; Shunda Du; Changjun Jia; Feng Xu; Jie Shi; Juxian Sun; Peng Zhu; Satoshi Nara; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

4.  Reply to "Application of contrast-enhanced intraoperative ultrasonography in the decision-making about hepatocellular carcinoma operation".

Authors:  Matteo Donadon; Guido Torzilli
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

Review 5.  Hepatic resection beyond barcelona clinic liver cancer indication: When and how.

Authors:  Mattia Garancini; Enrico Pinotti; Stefano Nespoli; Fabrizio Romano; Luca Gianotti; Vittorio Giardini
Journal:  World J Hepatol       Date:  2016-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.